Tag Archives: Oncology
By Julian Upton | Published: February 11, 2014
Approximately $12.7 billion has been invested in Latin America’s (LATAM’s) pharmaceutical market through mergers and acquisitions (M&As) in recent years. And with untapped potential identified in countries across the region, companies are expected to seize upon further opportunities to drive future growth, says a new report from GlobalData.
By Guest Blogger | Published: November 12, 2013
By Howard Deutsch, Associate Principal, ZS Associates (Sponsored Content) Oncology-market access doesn’t “just happen” anymore. As competition in the U.S. health-care market only continues to intensify, oncology-drug companies will need a good corporate strategy to ensure physician uptake and payer coverage of therapies. Having strong clinical data isn’t enough, especially as stakeholders grow ever more […]
By Guest Blogger | Published: October 23, 2013
Sharon Karlsberg, Principal, ZS Associates (Sponsored Content) While buzz on Twitter will never outweigh critical data in a peer-reviewed publication, social media is becoming an important part of our industry’s dialogue. The oncology market is no exception, as insight gleaned from recent Twitter traffic and trends reveals.
By Guest Blogger | Published: October 18, 2013
by Stan Bernard and Janet Wells Like the Super Bowl, pharma companies are winning major congresses by using competitive conference techniques to generate brand buzz and corporate recognition. Each year, thirty-two National Football League teams compete to win the Super Bowl, the ultimate U.S. team sport championship. Simultaneously, dozens of major companies are also competing […]
By Ben Comer | Published: August 1, 2013
Eight months into the launch of its first approved drug – Iclusig (ponatinib), a small molecule therapy indicated for two rare forms of leukemia – Ariad Pharmaceuticals’ principal founder and CEO Harvey Berger says doing it all, from discovery to global commercialization, is the company’s path to sustainability and the way to take on Big […]